27.11.2014 Views

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />

Chapter 11: Postexposure Prophylaxis<br />

CASES<br />

1.<br />

An employee states that she has just punctured herself <strong>with</strong> a needle after drawing a patient’s blood. The<br />

patient has already left the clinic and no one knows anything about his medical his<strong>to</strong>ry. The employee<br />

completed the HBV vaccination series and is hepatitis B surface antibody (HBsAb) positive. During the<br />

investigation the <strong>HIV</strong> prevalence in this setting was found <strong>to</strong> be low.<br />

Question: What is the risk <strong>of</strong> <strong>HIV</strong> transmission?<br />

Answer:<br />

The risk <strong>of</strong> <strong>HIV</strong> transmission after a puncture wound <strong>with</strong> a hollow-bore needle is 0.3%. It is important <strong>to</strong><br />

remember that the risk <strong>of</strong> infection is higher when there is a large-volume exposure, a deep percutaneous<br />

injury, or an injury <strong>with</strong> a hollow-bore, blood-filled needle, or if the source has advanced <strong>HIV</strong> disease<br />

or has a high level <strong>of</strong> <strong>HIV</strong> viremia. The current CDC recommendations advise against <strong>HIV</strong> PEP when the<br />

source is unknown and in settings where the <strong>HIV</strong> prevalence is low.<br />

Question: What counseling and followup should be recommended?<br />

Answer:<br />

Because <strong>of</strong> the low prevalence <strong>of</strong> <strong>HIV</strong> in this setting, the employee should be advised against taking <strong>HIV</strong><br />

medications. Also, because she is HBsAb positive she is not a candidate for HBV PEP. The HCP should be<br />

advised <strong>to</strong> refrain from donating blood, plasma, organs, or tissue, <strong>to</strong> use barrier methods during sexual<br />

activities, and <strong>to</strong> refrain from sharing any injection or other drug use equipment. She should also be<br />

counseled about universal precautions and administration should take steps <strong>to</strong> reduce the risk <strong>of</strong> future<br />

accidental needle sticks. She should be educated about the symp<strong>to</strong>ms <strong>of</strong> acute <strong>HIV</strong> and advised <strong>to</strong> return<br />

immediately if those symp<strong>to</strong>ms occur. Mental health counseling should also be <strong>of</strong>fered.<br />

A baseline <strong>HIV</strong> antibody and anti-HCV should be drawn. <strong>HIV</strong> anibody should be repeated at 6 weeks, 3<br />

months and 6 months after exposure. A 12-month followup is recommended if the source is found <strong>to</strong> be<br />

coinfected <strong>with</strong> <strong>HIV</strong> and HCV, or if the exposed becomes infected <strong>with</strong> HCV following exposure. Anti-HCV<br />

and ALT should be repeated <strong>with</strong>in 4-6 months and if positive should be confirmed <strong>with</strong> supplemental tests.<br />

11<br />

U.S. Department <strong>of</strong> Health and Human Services, Health Resources and Services Administration, <strong>HIV</strong>/<strong>AIDS</strong> Bureau<br />

95

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!